Guideline Central Blog

FDA Approvals

FDA Approvals - May 2024

Guideline Med Alerts & FDA Approvals – May 2024

Breyanzi (Bristol Myers Squibb)Expanded Indication Retevmo (Eli Lilly) Expanded Indication Onyda XR (Tris Pharma)  Bkemv (Amgen)Biosimilar to Soliris Opuviz (Biogen) Biosimilar to Eylea Yesafili (Biocon Biologics) Biosimilar to Eylea Imdelltra (Amgen)  Clinolipid (Baxter) Expanded Indication ColoSense (Geneoscopy) New Formulation Myhibbin (Azurity Pharmaceuticals) New Formulation Cyltezo (Boehringer Ingelheim) New Formulation Sign up for alerts and stay informed on […]

Guidelines Rundown Tuberculosis

Tuberculosis – Guidelines Rundown

Our Guidelines Rundown Series progresses with a new article focused on tuberculosis. Numerous guidelines on tuberculosis are currently available, published by nearly a dozen different medical societies and organizations. The most recent guideline, issued by the World Health Organization, stands out as it leads the global initiative to eradicate tuberculosis by advocating for universal access […]

Mechanical Ventilation - Guidelines Rundown

Mechanical Ventilation – Guidelines Rundown

Our Guidelines Rundown Series continues with a new article focusing on mechanical ventilation. There are many current guidelines on mechanical ventilation, published by over a half dozen different medical societies. These guidelines both cover mechanical ventilation in a broad sense, as well as in specific situations, such as prevention of VAP. Today we’re going to […]

What’s New in Infectious Diseases So Far Through April 2024 – Guidelines Rundown

Today, we will be providing an overview of the latest developments in the field of Infectious Diseases up to April 2024. This includes new medications, new guidelines, and noteworthy research and journal articles that have been published in the first four months of the year. Recent Infectious Diseases-Related Clinical Guidelines Recent Infectious Disease-Related FDA Medication […]